Resultados de la búsqueda 561-570 of 10508 for monoclonal antibody

  1. Oncología (médica) - Ensayos clínicos

    Immunotoxins, such as inotuzumab ozogamicin, are antibodies linked to a toxic substance and may help find cancer cells that express CD22 and kill them without ...

  2. Alto nivel de proteínas presentes en la sangre Causes - Mayo Clinic

    Hepatitis B · Hepatitis C · VIH/sida · Gammapatía monoclonal de significado incierto · Mieloma múltiple. Una alimentación con alto contenido de proteínas no ...

  3. Médicos - Atención para el cáncer en Mayo Clinic

    Médicos · Ejigayehu G. Abate, M.D. · Nadine H. Abdallah, M.D. · Jithma P. Abeykoon, M.D. · Joseph M. Accurso, M.D. · Pooja P. · Safia K. · Daniel H. · Edward S.

  4. Transplant Center de Mayo Clinic - Ensayos clínicos

    The purpose of this study is to investigate how efficiently the study medication imlifidase reduces the amount of donor specific antibodies (DSA) in comparison ...

  5. Mayo Clinic Digestive Diseases Physician Update e-Edition, April 2015

    Surgeons have been slow to adopt laparoscopic pancreaticoduodenectomy (PD). · Research · A majority of patients with fecal incontinence experience at least a 50 ...

  6. Radiología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to learn more about the distribution of the pathological protein tau in the living brains of patients with Progressive Supranuclear ...

  7. Transplant Center de Mayo Clinic - Ensayos clínicos

    The purpose of this study is to investigate how efficiently the study medication imlifidase reduces the amount of donor specific antibodies (DSA) in comparison ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This is a Phase I/II study designed to evaluate if experimental anti-TIGIT/anti-PD-1 bispecific antibody rilvegostomig (AZD2936) is safe, tolerable and ...

  9. Transplant Center de Mayo Clinic - Ensayos clínicos

    The purpose of this study is to investigate how efficiently the study medication imlifidase reduces the amount of donor specific antibodies (DSA) in comparison ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This is a Phase I/II study designed to evaluate if experimental anti-TIGIT/anti-PD-1 bispecific antibody rilvegostomig (AZD2936) is safe, tolerable and ...